Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02997176
Title An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800)
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Medivation, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UCLA Hematology/Oncology - Alhambra Alhambra California 91801 United States Details
CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center Bakersfield California 93309 United States Details
St. Joseph Heritage Healthcare Fullerton California 92835 United States Details
St. Jude Hospital Yorba Linda DBA St. Joseph Heritage Healthcare Fullerton California 92835 United States Details
UCLA Hematology/Oncology Los Angeles California 90095 United States Details
UCLA Hematology/Oncology - Porter Ranch Porter Ranch California 91326 United States Details
UCLA Hematology/Oncology - Santa Monica Santa Monica California 90404 United States Details
UCLA Torrance Oncology Torrance California 90505 United States Details
UCLA Hematology/Oncology - Santa Clarita Valencia California 91355 United States Details
Orlando Health, Inc. Orlando Florida 32806 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field